Jump to content

Warner–Lambert

From Wikipedia, the free encyclopedia
Warner–Lambert
Company typePrivate
IndustryPharmaceutical
Founded1856; 168 years ago (1856)
Philadelphia, Pennsylvania, U.S.
FounderWilliam R. Warner
Defunct2000; 24 years ago (2000)
FateAcquired by Pfizer in 2000
Headquarters
Morris Plains Edit this on Wikidata
ParentPfizer

Warner–Lambert was an American pharmaceutical company.

History

[edit]

Formerly two separate entities, the first company was started in 1856, when William R. Warner founded a drug store in Philadelphia. Warner went on to invent a tablet coating process gaining him a place in the Smithsonian Institution. William R. Warner and Company Limited acquired several other cosmetics companies in the early 20th century, and was renamed Warner-Hudnut, Inc. in 1950.[1] The second half of the name came from Jordan Wheat Lambert, founder of the Lambert Pharmacal Company of St. Louis,[2] famous for Listerine. The two companies merged in 1955, to form Warner–Lambert.[3]

Over the years, the company expanded through many mergers and acquisitions to become an international competitor in several businesses. In 1956, Warner–Lambert acquired Nepera Chemical (the makers of Anahist) from the Lasdon family, many of whom then became officers and directors of the merged business.[4]

In 1962, Warner-Lambert bought American Chicle, one of the world's largest manufacturers of gums and mints. The 1965 acquisition of a small cough tablet company in the United Kingdom resulted in the success of the Halls Mentho-Lyptus brand on a global scale. In 1970, Warner-Lambert bought the Schick razor blade company, founded in 1926 by Jacob Schick. In the same year, they also took over Parke-Davis, founded in Detroit in 1866, by Hervey Parke and George Davis. This was followed by acquisitions of Wilkinson Sword in March 1993, and Agouron Pharmaceuticals in January 1999.[5][6]

Its subsidiary Parke-Davis marketed the antidiabetic drug Rezulin, which was approved by the FDA in January 1997 but withdrawn by them in early 2000.

In the end of the 1990s, Warner–Lambert formed an alliance with Pfizer to bring its drug Lipitor to market. Lipitor launched in January 1997 to resounding success, reaching $1B in domestic sales within its first twelve months on the market.[7] By 1999, Warner-Lambert was in agreement to merge with American Home Products, before Pfizer made its own offer to acquire the company.[8][9] In February 2000, Pfizer bought Warner Lambert along with all of its subsidiary companies.[10] The headquarters of Warner–Lambert in Morris Plains, New Jersey, was subsequently used by Pfizer, Johnson & Johnson, and Honeywell.

References

[edit]
  1. ^ The Science Museum Group: William R. Warner and Company Limited
  2. ^ "Lambert Pharmacal Company". www.rdhinstl.com. Retrieved June 3, 2019.
  3. ^ "Pfizer Warner Lambert". WARNER LAMBERT. Retrieved 2023-08-02.
  4. ^ Pace, Eric (December 10, 1984). "W.S. Lasdon, philanthropist and a drug executive, dies". The New York Times.
  5. ^ "Company news; Warner-Lambert acquires Wilkinson Sword". The New York Times. March 23, 1993. Retrieved May 27, 2018.
  6. ^ "Warner-Lambert to Acquire Agouron Pharmaceuticals". The New York Times. January 27, 1999. Retrieved May 27, 2018.
  7. ^ Koberstein, Wayne (May 1998). "Master Launchers". Pharmaceutical Executive.
  8. ^ "Warner-Lambert and American Home Products to Merge, Forming World's Largest Pharm/Consumer Health Company". Pharmaceutical Online. November 4, 1999. Retrieved 2024-06-10.
  9. ^ Jacobs, Paul (1999-11-05). "Pfizer Offers More to Lure Warner-Lambert From American Home". Los Angeles Times. Retrieved 2024-06-10.
  10. ^ "Pfizer Gets Its Deal to Buy Warner-Lambert for $90.2 Billion". The New York Times. February 7, 2000. Retrieved May 27, 2018.
[edit]
Retrieved from "https://en.wikipedia.org/w/index.php?title=Warner–Lambert&oldid=1253346178"